MicroRNAs are central regulators of DLBCL biology and show strong potential as minimally invasive biomarkers to improve ...
An efficient neural screening approach rapidly identifies circuit modules governing distinct behavioral transitions in response to pathogen exposure.
Background Current diagnosis of antiphospholipid syndrome (APS) relies on antiphospholipid antibodies (aPL) testing, but false-positive aPL results and asymptomatic aPL carriers pose significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results